A collaborative research team has successfully developed a novel fluorescent probe, SLY (Sialyl Lewis Yellow), capable of ...

Cancer does not develop overnight. It can take decades for cancer‐promoting changes in the genome to eventually lead to the ...

The Chan Zuckerberg Initiative (CZI) reports its latest AI model aimed at helping researchers better understand how cells ...

Molecular vibrations, when paired with near-infrared (NIR) light, have opened a new chapter in cancer treatment. Instead of ...

The fluorescent labeling compound—dubbed "Sialyl Lewis Yellow"—was developed by an international team led from the Pohang University of Science and Technology in South Korea. It works by binding to ...

In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...

Kazia Therapeutics (NASDAQ:KZIA) on Wednesday reported preliminary results from the first patient in its Phase 1b trial ...

Immunologists at UNIGE have revealed a previously unknown anti-tumor role of CD4 T lymphocytes, marking a breakthrough that ...

T cell-based immunotherapy, a form of cancer treatment, harnesses a patient’s own T cells — white blood cells that help fight ...

The two types of uterine cancer are endometrial cancer and uterine sarcoma. Each of these types has several subtypes.

This new article publication from Acta Pharmaceutica Sinica B, discusses how ALKBH3-regulated m1A of ALDOA potentiates ...

Studies show in mice show that targeting the metabolic pathways could inhibit the growth of melanoma and combining this ...